Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy

NCT07565415 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)
Cachexia
Anorexia
Malnutrition

Interventions

DRUG: Nanocrystalline megestrol acetate
DRUG: Placebo

Sponsor

Nanfang Hospital, Southern Medical University